These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 15181128

  • 1. Reduced blood flow and preserved vasoreactivity characterize oxygen hypometabolism due to incomplete infarction in occlusive carotid artery diseases.
    Kuroda S, Shiga T, Ishikawa T, Houkin K, Narita T, Katoh C, Tamaki N, Iwasaki Y.
    J Nucl Med; 2004 Jun; 45(6):943-9. PubMed ID: 15181128
    [Abstract] [Full Text] [Related]

  • 2. Cerebral oxygen metabolism and neuronal integrity in patients with impaired vasoreactivity attributable to occlusive carotid artery disease.
    Kuroda S, Shiga T, Houkin K, Ishikawa T, Katoh C, Tamaki N, Iwasaki Y.
    Stroke; 2006 Feb; 37(2):393-8. PubMed ID: 16385090
    [Abstract] [Full Text] [Related]

  • 3. Reduced blood flow response to acetazolamide reflects pre-existing vasodilation and decreased oxygen metabolism in major cerebral arterial occlusive disease.
    Yamauchi H, Okazawa H, Kishibe Y, Sugimoto K, Takahashi M.
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1349-56. PubMed ID: 12271418
    [Abstract] [Full Text] [Related]

  • 4. Accuracy of central benzodiazepine receptor binding potential/cerebral blood flow SPECT imaging for detecting misery perfusion in patients with unilateral major cerebral artery occlusive diseases: comparison with cerebrovascular reactivity to acetazolamide and cerebral blood flow SPECT imaging.
    Kuroda H, Ogasawara K, Suzuki T, Chida K, Aso K, Kobayashi M, Yoshida K, Terasaki K, Fujiwara S, Kubo Y, Ogawa A.
    Clin Nucl Med; 2012 Mar; 37(3):235-40. PubMed ID: 22310248
    [Abstract] [Full Text] [Related]

  • 5. Diastolic blood pressure influences cerebrovascular reactivity measured by means of 123I-iodoamphetamine brain single photon emission computed tomography in medically treated patients with occlusive carotid or middle cerebral artery disease.
    Kimura Y, Oku N, Kajimoto K, Katoh H, Tanaka MR, Takasawa M, Imaizumi M, Kitagawa K, Hori M, Hatazawa J.
    Ann Nucl Med; 2006 Apr; 20(3):209-15. PubMed ID: 16715952
    [Abstract] [Full Text] [Related]

  • 6. Clinical implication and prognosis of normal baseline cerebral blood flow with impaired vascular reserve in patients with major cerebral artery occlusive disease.
    Isozaki M, Arai Y, Kudo T, Kiyono Y, Kobayashi M, Kubota T, Kikuta K, Okazawa H.
    Ann Nucl Med; 2010 Jun; 24(5):371-7. PubMed ID: 20238185
    [Abstract] [Full Text] [Related]

  • 7. Acetazolamide reactivity on 123I-IMP single photon emission computed tomography in patients with major cerebral artery occlusive disease: correlation with positron emission tomography parameters.
    Hirano T, Minematsu K, Hasegawa Y, Tanaka Y, Hayashida K, Yamaguchi T.
    J Cereb Blood Flow Metab; 1994 Sep; 14(5):763-70. PubMed ID: 8063872
    [Abstract] [Full Text] [Related]

  • 8. Central benzodiazepine receptor binding potential and CBF images on SPECT correlate with oxygen extraction fraction images on PET in the cerebral cortex with unilateral major cerebral artery occlusive disease.
    Chida K, Ogasawara K, Kuroda H, Aso K, Kobayashi M, Fujiwara S, Yoshida K, Terasaki K, Ogawa A.
    J Nucl Med; 2011 Apr; 52(4):511-8. PubMed ID: 21421729
    [Abstract] [Full Text] [Related]

  • 9. Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: a PET study with the acetazolamide test in cerebrovascular disease.
    Okazawa H, Yamauchi H, Toyoda H, Sugimoto K, Fujibayashi Y, Yonekura Y.
    J Nucl Med; 2003 Dec; 44(12):1875-83. PubMed ID: 14660711
    [Abstract] [Full Text] [Related]

  • 10. PET OEF reactivity for hemodynamic compromise in occlusive vascular disease.
    Nemoto EM, Yonas H, Pindzola RR, Kuwabara H, Sashin D, Chang Y, Jovin T.
    J Neuroimaging; 2007 Jan; 17(1):54-60. PubMed ID: 17238870
    [Abstract] [Full Text] [Related]

  • 11. Impact of oxygen extraction fraction on long-term prognosis in patients with reduced blood flow and vasoreactivity because of occlusive carotid artery disease.
    Hokari M, Kuroda S, Shiga T, Nakayama N, Tamaki N, Iwasaki Y.
    Surg Neurol; 2009 May; 71(5):532-8; discussion 538, 538-9. PubMed ID: 18514278
    [Abstract] [Full Text] [Related]

  • 12. Differences in vasodilatory capacity and changes in cerebral blood flow induced by acetazolamide in patients with cerebrovascular disease.
    Okazawa H, Yamauchi H, Sugimoto K, Takahashi M.
    J Nucl Med; 2003 Sep; 44(9):1371-8. PubMed ID: 12960179
    [Abstract] [Full Text] [Related]

  • 13. Preoperative central benzodiazepine receptor binding potential and cerebral blood flow images on SPECT predict development of new cerebral ischemic events and cerebral hyperperfusion after carotid endarterectomy.
    Sato Y, Ogasawara K, Kuroda H, Suzuki T, Chida K, Fujiwara S, Aso K, Kobayashi M, Yoshida K, Terasaki K, Ogawa A.
    J Nucl Med; 2011 Sep; 52(9):1400-7. PubMed ID: 21795362
    [Abstract] [Full Text] [Related]

  • 14. Clinical significance of STA-MCA double anastomosis for hemodynamic compromise in post-JET/COSS era.
    Kuroda S, Kawabori M, Hirata K, Shiga T, Kashiwazaki D, Houkin K, Tamaki N.
    Acta Neurochir (Wien); 2014 Jan; 156(1):77-83. PubMed ID: 24292807
    [Abstract] [Full Text] [Related]

  • 15. Differentiating hemodynamic compromise by the OEF response to acetazolamide in occlusive vascular disease.
    Nemoto EM, Yonas H, Kuwabara H, Pindzola R, Sashin D, Chang Y, Jovin T, Gebel J, Hammer MD, Wechsler L.
    Adv Exp Med Biol; 2005 Jan; 566():135-41. PubMed ID: 16594145
    [Abstract] [Full Text] [Related]

  • 16. Effect of combination therapy with the angiotensin receptor blocker losartan plus hydrochlorothiazide on brain perfusion in patients with both hypertension and cerebral hemodynamic impairment due to symptomatic chronic major cerebral artery steno-occlusive disease: a SPECT study.
    Saura H, Ogasawara K, Suzuki T, Kuroda H, Yamashita T, Kobayashi M, Terasaki K, Ogawa A.
    Cerebrovasc Dis; 2012 Jan; 33(4):354-61. PubMed ID: 22433127
    [Abstract] [Full Text] [Related]

  • 17. Clinical significance of cerebrovascular reserve in acetazolamide challenge -comparison with acetazolamide challenge H2O-PET and Gas-PET.
    Imaizumi M, Kitagawa K, Oku N, Hashikawa K, Takasawa M, Yoshikawa T, Osaki Y, Matsushita K, Matsumoto M, Hori M, Hatazawa J.
    Ann Nucl Med; 2004 Jul; 18(5):369-74. PubMed ID: 15462398
    [Abstract] [Full Text] [Related]

  • 18. Cerebral hemodynamic evaluation using perfusion-weighted magnetic resonance imaging: comparison with positron emission tomography values in chronic occlusive carotid disease.
    Kajimoto K, Moriwaki H, Yamada N, Hayashida K, Kobayashi J, Miyashita K, Naritomi H.
    Stroke; 2003 Jul; 34(7):1662-6. PubMed ID: 12791940
    [Abstract] [Full Text] [Related]

  • 19. Combination of a mean transit time measurement with an acetazolamide test increases predictive power to identify elevated oxygen extraction fraction in occlusive carotid artery diseases.
    Hokari M, Kuroda S, Shiga T, Nakayama N, Tamaki N, Iwasaki Y.
    J Nucl Med; 2008 Dec; 49(12):1922-7. PubMed ID: 18997043
    [Abstract] [Full Text] [Related]

  • 20. Detection of misery perfusion with split-dose 123I-iodoamphetamine single-photon emission computed tomography in patients with carotid occlusive diseases.
    Imaizumi M, Kitagawa K, Hashikawa K, Oku N, Teratani T, Takasawa M, Yoshikawa T, Rishu P, Ohtsuki T, Hori M, Matsumoto M, Nishimura T.
    Stroke; 2002 Sep; 33(9):2217-23. PubMed ID: 12215590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.